FGFR2 and neoplasm: The distance between CD11b+/CD15+ granulocytes and tumor cells, as well as both CD8+ and CD4+ T-cell subsets, was reduced as compared to IDH1+ iCCA and FGFR2 WT/IDH1 WT iCCA (p<0.001 for all comparisons).